Download PDF
Semin Neurol 2010; 30(5): 545-554
DOI: 10.1055/s-0030-1268862
© Thieme Medical Publishers

Aneurysmal Subarachnoid Hemorrhage: An Overview for the Practicing Neurologist

Stefan A. Dupont1 , Eelco F.M Wijdicks1 , Giuseppe Lanzino1 , Alejandro A. Rabinstein1
  • 1Department of Neurology and Neurosurgery, Mayo Clinic, Rochester, Minnesota
Further Information

Publication History

Publication Date:
04 January 2011 (online)

    Permissions and Reprints

ABSTRACT

Subarachnoid hemorrhage (SAH) accounts for ~5% of strokes, but causes high rates of morbidity and mortality and occurs at a relatively young age. The rupture of an intracranial aneurysm is the leading cause of nontraumatic SAH and will be the subject of this review. Rebleeding remains the most imminent danger until the aneurysm is secured (i.e., excluded from the cerebral circulation). Therefore, prompt aneurysm treatment is crucial to minimize this risk. Endovascular occlusion of the aneurysm with coils has been shown to be associated with better short- and long-term outcomes than surgical clipping in select patients. Yet, angiographic surveillance is necessary after endovascular treatment and retreatment with additional coiling may be required. Delayed cerebral vasospasm is the leading cause of brain damage once the aneurysm has been treated. Hemodynamic augmentation therapy remains the mainstay of medical treatment, but various agents are being tested as means to prevent or ameliorate vasospasm, including magnesium sulfate, statins, and an endothelin antagonist. Medically refractory vasospasm demands angioplasty of the affected vessel or intraarterial infusion of vasodilators. In this review, the authors provide an overview of the diagnosis and management of aneurysmal SAH with an emphasis on these main topics.

KEYWORDS

Subarachnoid hemorrhage - cerebral aneurysm - vasospasm - hydrocephalus - delayed cerebral infarction

REFERENCES

  • 1 Day J W, Raskin N H. Thunderclap headache: symptom of unruptured cerebral aneurysm.  Lancet. 1986;  2 (8518) 1247-1248
    PubMedGoogle Scholar
  • 2 Fontanarosa P B. Recognition of subarachnoid hemorrhage.  Ann Emerg Med. 1989;  18 (11) 1199-1205
    CrossrefPubMedGoogle Scholar
  • 3 Sundaram M B, Chow F. Seizures associated with spontaneous subarachnoid hemorrhage.  Can J Neurol Sci. 1986;  13 (3) 229-231
    PubMedGoogle Scholar
  • 4 Rabinstein A A, Lanzino G, Wijdicks E FM. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage.  Lancet Neurol. 2010;  9 (5) 504-519
    CrossrefPubMedGoogle Scholar
  • 5 Bederson J B, Connolly Jr E S, Batjer H H American Heart Association et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.  Stroke. 2009;  40 (3) 994-1025
    CrossrefPubMedGoogle Scholar
  • 6 Jellinger K. Pathology of intracerebral hemorrhage.  Zentralbl Neurochir. 1977;  38 (1) 29-42
    PubMedGoogle Scholar
  • 7 Jakubowski J, Kendall B. Coincidental aneurysms with tumours of pituitary origin.  J Neurol Neurosurg Psychiatry. 1978;  41 (11) 972-979
    CrossrefPubMedGoogle Scholar
  • 8 Wiebers D O, Whisnant J P, Huston III J International Study of Unruptured Intracranial Aneurysms Investigators et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment.  Lancet. 2003;  362 (9378) 103-110
    Google Scholar
  • 9 Phillips II L H, Whisnant J P, O'Fallon W M, Sundt Jr T M. The unchanging pattern of subarachnoid hemorrhage in a community.  Neurology. 1980;  30 (10) 1034-1040
    CrossrefPubMedGoogle Scholar
  • 10 van Gijn J, Rinkel G J. Subarachnoid haemorrhage: diagnosis, causes and management.  Brain. 2001;  124 (Pt 2) 249-278
    CrossrefPubMedGoogle Scholar
  • 11 Qureshi A I, Suri M F, Yahia A M et al.. Risk factors for subarachnoid hemorrhage.  Neurosurgery. 2001;  49 (3) 607-612, discussion 612–613
    CrossrefPubMedGoogle Scholar
  • 12 Oyesiku N M, Colohan A R, Barrow D L, Reisner A. Cocaine-induced aneurysmal rupture: an emergent negative factor in the natural history of intracranial aneurysms?.  Neurosurgery. 1993;  32 (4) 518-525, discussion 525–526
    CrossrefPubMedGoogle Scholar
  • 13 Landtblom A M, Fridriksson S, Boivie J, Hillman J, Johansson G, Johansson I. Sudden onset headache: a prospective study of features, incidence and causes.  Cephalalgia. 2002;  22 (5) 354-360
    CrossrefPubMedGoogle Scholar
  • 14 Hauerberg J, Andersen B B, Eskesen V, Rosenørn J, Schmidt K. Importance of the recognition of a warning leak as a sign of a ruptured intracranial aneurysm.  Acta Neurol Scand. 1991;  83 (1) 61-64
    CrossrefPubMedGoogle Scholar
  • 15 Dupont S A, Lanzino G, Wijdicks E FM, Rabinstein A A. The use of clinical and routine imaging data to differentiate between aneurysmal and nonaneurysmal subarachnoid hemorrhage prior to angiography.  J Neurosurg. 2010;  113 (4) 790-794
    CrossrefPubMedGoogle Scholar
  • 16 Edlow J ACL, Caplan L R. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage.  N Engl J Med. 2000;  342 (1) 29-36
    CrossrefPubMedGoogle Scholar
  • 17 Kowalski R G, Claassen J, Kreiter K T et al.. Initial misdiagnosis and outcome after subarachnoid hemorrhage.  JAMA. 2004;  291 (7) 866-869
    CrossrefPubMedGoogle Scholar
  • 18 van der Wee N, Rinkel G J, Hasan D, van Gijn J. Detection of subarachnoid haemorrhage on early CT: is lumbar puncture still needed after a negative scan?.  J Neurol Neurosurg Psychiatry. 1995;  58 (3) 357-359
    CrossrefPubMedGoogle Scholar
  • 19 Fisher C M, Kistler J P, Davis J M. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning.  Neurosurgery. 1980;  6 (1) 1-9
    CrossrefPubMedGoogle Scholar
  • 20 Mitchell P, Wilkinson I D, Hoggard N et al.. Detection of subarachnoid haemorrhage with magnetic resonance imaging.  J Neurol Neurosurg Psychiatry. 2001;  70 (2) 205-211
    CrossrefPubMedGoogle Scholar
  • 21 Mayberg M R, Batjer H H, Dacey R et al.. Guidelines for the management of aneurysmal subarachnoid haemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.  Stroke. 1994;  25 2315-2328
    CrossrefPubMedGoogle Scholar
  • 22 Dupont S A, Wijdicks E FM, Manno E M, Rabinstein A A. Thunderclap headache and normal computed tomographic results: value of cerebrospinal fluid analysis.  Mayo Clin Proc. 2008;  83 (12) 1326-1331
    CrossrefPubMedGoogle Scholar
  • 23 Kaufmann T J, Huston III J, Mandrekar J N, Schleck C D, Thielen K R, Kallmes D F. Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients.  Radiology. 2007;  243 (3) 812-819
    CrossrefPubMedGoogle Scholar
  • 24 McKinney A M, Palmer C S, Truwit C L, Karagulle A, Teksam M. Detection of aneurysms by 64-section multidetector CT angiography in patients acutely suspected of having an intracranial aneurysm and comparison with digital subtraction and 3D rotational angiography.  AJNR Am J Neuroradiol. 2008;  29 (3) 594-602
    CrossrefPubMedGoogle Scholar
  • 25 Kassell N F, Torner J C. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study.  Neurosurgery. 1983;  13 (5) 479-481
    CrossrefPubMedGoogle Scholar
  • 26 Rosenørn J, Eskesen V, Schmidt K, Rønde F. The risk of rebleeding from ruptured intracranial aneurysms.  J Neurosurg. 1987;  67 (3) 329-332
    CrossrefPubMedGoogle Scholar
  • 27 Molyneux A J, Kerr R SC, Yu L M International Subarachnoid Aneurysm Trial (ISAT) Collaborative Group et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.  Lancet. 2005;  366 (9488) 809-817
    Google Scholar
  • 28 Broderick J. Clipping or coiling: the first step for ruptured aneurysms.  Lancet Neurol. 2009;  8 414-415
    CrossrefPubMedGoogle Scholar
  • 29 Torner J C, Kassell N F, Wallace R B, Adams Jr H P. Preoperative prognostic factors for rebleeding and survival in aneurysm patients receiving antifibrinolytic therapy: report of the Cooperative Aneurysm Study.  Neurosurgery. 1981;  9 (5) 506-513
    CrossrefPubMedGoogle Scholar
  • 30 Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson K E. Immediate administration of tranexamic acid and reduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study.  J Neurosurg. 2002;  97 (4) 771-778
    CrossrefPubMedGoogle Scholar
  • 31 Vale F L, Bradley E L, Fisher III W S. The relationship of subarachnoid hemorrhage and the need for postoperative shunting.  J Neurosurg. 1997;  86 (3) 462-466
    CrossrefPubMedGoogle Scholar
  • 32 ter Laan M, Mooij J JA. Improvement after treatment of hydrocephalus in aneurysmal subarachnoid haemorrhage: implications for grading and prognosis.  Acta Neurochir (Wien). 2006;  148 (3) 325-328, discussion 328
    CrossrefPubMedGoogle Scholar
  • 33 Black P M. Hydrocephalus and vasospasm after subarachnoid hemorrhage from ruptured intracranial aneurysms.  Neurosurgery. 1986;  18 (1) 12-16
    CrossrefPubMedGoogle Scholar
  • 34 Graff-Radford N R, Torner J, Adams Jr H P, Kassell N F. Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.  Arch Neurol. 1989;  46 (7) 744-752
    CrossrefPubMedGoogle Scholar
  • 35 Hasan D, Tanghe H L. Distribution of cisternal blood in patients with acute hydrocephalus after subarachnoid hemorrhage.  Ann Neurol. 1992;  31 (4) 374-378
    CrossrefPubMedGoogle Scholar
  • 36 Hasan D, Vermeulen M, Wijdicks E F, Hijdra A, van Gijn J. Management problems in acute hydrocephalus after subarachnoid hemorrhage.  Stroke. 1989;  20 (6) 747-753
    CrossrefPubMedGoogle Scholar
  • 37 Mehta V, Holness R O, Connolly K, Walling S, Hall R. Acute hydrocephalus following aneurysmal subarachnoid hemorrhage.  Can J Neurol Sci. 1996;  23 (1) 40-45
    CrossrefPubMedGoogle Scholar
  • 38 Hasan D, Lindsay K W, Vermeulen M. Treatment of acute hydrocephalus after subarachnoid hemorrhage with serial lumbar puncture.  Stroke. 1991;  22 (2) 190-194
    CrossrefPubMedGoogle Scholar
  • 39 Wong G KC, Poon W S, Wai S, Yu L M, Lyon D, Lam J MK. Failure of regular external ventricular drain exchange to reduce cerebrospinal fluid infection: result of a randomised controlled trial.  J Neurol Neurosurg Psychiatry. 2002;  73 (6) 759-761
    CrossrefPubMedGoogle Scholar
  • 40 Hellingman C A, van den Bergh W M, Beijer I S et al.. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage.  Stroke. 2007;  38 (1) 96-99
    CrossrefPubMedGoogle Scholar
  • 41 McIver J I, Friedman J A, Wijdicks E FM et al.. Preoperative ventriculostomy and rebleeding after aneurysmal subarachnoid hemorrhage.  J Neurosurg. 2002;  97 (5) 1042-1044
    CrossrefPubMedGoogle Scholar
  • 42 Wijdicks E F, Vermeulen M, ten Haaf J A, Hijdra A, Bakker W H, van Gijn J. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm.  Ann Neurol. 1985;  18 (2) 211-216
    CrossrefPubMedGoogle Scholar
  • 43 Rabinstein A A, Wijdicks E FM. Hyponatremia in critically ill neurological patients.  Neurologist. 2003;  9 (6) 290-300
    CrossrefPubMedGoogle Scholar
  • 44 Mori T, Katayama Y, Kawamata T, Hirayama T. Improved efficiency of hypervolemic therapy with inhibition of natriuresis by fludrocortisone in patients with aneurysmal subarachnoid hemorrhage.  J Neurosurg. 1999;  91 (6) 947-952
    CrossrefPubMedGoogle Scholar
  • 45 Suarez J I, Qureshi A I, Parekh P D et al.. Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage.  J Neurosurg Anesthesiol. 1999;  11 (3) 178-184
    CrossrefPubMedGoogle Scholar
  • 46 Frontera J A, Fernandez A, Schmidt J M et al.. Defining vasospasm after subarachnoid hemorrhage: what is the most clinically relevant definition?.  Stroke. 2009;  40 (6) 1963-1968
    CrossrefPubMedGoogle Scholar
  • 47 Rabinstein A A, Friedman J A, Weigand S D et al.. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.  Stroke. 2004;  35 (8) 1862-1866
    CrossrefPubMedGoogle Scholar
  • 48 Dupont S A, Wijdicks E FM, Manno E M, Lanzino G, Rabinstein A A. Prediction of angiographic vasospasm after aneurysmal subarachnoid hemorrhage: value of the Hijdra sum scoring system.  Neurocrit Care. 2009;  11 (2) 172-176
    CrossrefPubMedGoogle Scholar
  • 49 Frontera J A, Claassen J, Schmidt J M et al.. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: the modified fisher scale.  Neurosurgery. 2006;  59 (1) 21-27, discussion 21–27
    CrossrefPubMedGoogle Scholar
  • 50 Claassen J, Bernardini G L, Kreiter K et al.. Effect of cisternal and ventricular blood on risk of delayed cerebral ischemia after subarachnoid hemorrhage: the Fisher scale revisited.  Stroke. 2001;  32 (9) 2012-2020
    CrossrefPubMedGoogle Scholar
  • 51 Dupont S A, Wijdicks E FM, Manno E M, Lanzino G, Brown Jr R D, Rabinstein A A. Timing of computed tomography and prediction of vasospasm after aneurysmal subarachnoid hemorrhage.  Neurocrit Care. 2009;  11 (1) 71-75
    CrossrefPubMedGoogle Scholar
  • 52 Chiang V L, Claus E B, Awad I A. Toward more rational prediction of outcome in patients with high-grade subarachnoid hemorrhage.  Neurosurgery. 2000;  46 (1) 28-35, discussion 35–36
    PubMedGoogle Scholar
  • 53 Lasner T M, Weil R J, Riina H A et al.. Cigarette smoking-induced increase in the risk of symptomatic vasospasm after aneurysmal subarachnoid hemorrhage.  [see comment] J Neurosurg. 1997;  87 (3) 381-384
    CrossrefPubMedGoogle Scholar
  • 54 Weir B K, Kongable G L, Kassell N F, Schultz J R, Truskowski L L, Sigrest A. Cigarette smoking as a cause of aneurysmal subarachnoid hemorrhage and risk for vasospasm: a report of the Cooperative Aneurysm Study.  J Neurosurg. 1998;  89 (3) 405-411
    CrossrefPubMedGoogle Scholar
  • 55 Vora Y Y, Suarez-Almazor M, Steinke D E, Martin M L, Findlay J M. Role of transcranial Doppler monitoring in the diagnosis of cerebral vasospasm after subarachnoid hemorrhage.  Neurosurgery. 1999;  44 (6) 1237-1247, discussion 1247–1248
    CrossrefPubMedGoogle Scholar
  • 56 Carrera E, Schmidt J M, Oddo M et al.. Transcranial Doppler for predicting delayed cerebral ischemia after subarachnoid hemorrhage.  Neurosurgery. 2009;  65 (2) 316-323, discussion 323–324
    CrossrefPubMedGoogle Scholar
  • 57 Rabinstein A A, Friedman J A, Weigand S D et al.. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage.  Stroke. 2004;  35 (8) 1862-1866
    CrossrefPubMedGoogle Scholar
  • 58 Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study.  Neurosurgery. 2001;  49 (3) 593-605, discussion 605–606
    CrossrefPubMedGoogle Scholar
  • 59 Lennihan L, Mayer S A, Fink M E et al.. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage : a randomized controlled trial.  Stroke. 2000;  31 (2) 383-391
    CrossrefPubMedGoogle Scholar
  • 60 Muizelaar J P, Becker D P. Induced hypertension for the treatment of cerebral ischemia after subarachnoid hemorrhage. Direct effect on cerebral blood flow.  Surg Neurol. 1986;  25 (4) 317-325
    CrossrefPubMedGoogle Scholar
  • 61 Ekelund A, Reinstrup P, Ryding E et al.. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.  Acta Neurochir (Wien). 2002;  144 (7) 703-712, discussion 712–713
    CrossrefPubMedGoogle Scholar
  • 62 Newell D W, Eskridge J M, Mayberg M R, Grady M S, Winn H R. Angioplasty for the treatment of symptomatic vasospasm following subarachnoid hemorrhage.  J Neurosurg. 1989;  71 (5 Pt 1) 654-660
    CrossrefPubMedGoogle Scholar
  • 63 Mathis J M, Jensen M E, Dion J E. Technical considerations on intra-arterial papaverine hydrochloride for cerebral vasospasm.  Neuroradiology. 1997;  39 (2) 90-98
    CrossrefPubMedGoogle Scholar
  • 64 Milburn J M, Moran C J, Cross III D T, Diringer M N, Pilgram T K, Dacey Jr R G. Increase in diameters of vasospastic intracranial arteries by intraarterial papaverine administration.  J Neurosurg. 1998;  88 (1) 38-42
    CrossrefPubMedGoogle Scholar
  • 65 Dorhout Mees S M, Rinkel G J, Feigin V L et al.. Calcium antagonists for aneurysmal subarachnoid haemorrhage.  Cochrane Database Syst Rev. 2007;  18 (3) CD000277
    PubMedGoogle Scholar
  • 66 Wong G K, Poon W S, Chan M T IMASH Investigators et al. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial.  Stroke. 2010;  41 (5) 921-926
    CrossrefPubMedGoogle Scholar
  • 67 Rabinstein A A. Vasospasm and statin therapy: yet another cautionary tale.  Neurocrit Care. 2010;  12 (2) 310-312
    CrossrefPubMedGoogle Scholar
  • 68 Macdonald R L, Kassell N F, Mayer S CONSCIOUS-1 Investigators et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial.  Stroke. 2008;  39 (11) 3015-3021
    CrossrefPubMedGoogle Scholar

Alejandro A RabinsteinM.D. 

Department of Neurology and Neurosurgery, Mayo Clinic

200 First Street SW, Rochester, MN 55905

Email: Rabinstein.Alejandro@Mayo.edu